Literature DB >> 2174705

Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

J Tor1, J M Llibre, M Carbonell, R Muga, A Ribera, V Soriano, B Clotet, M Sabriá, M Foz.   

Abstract

OBJECTIVE: To determine the extent of transmission of hepatitis C virus in sexual partners of intravenous drug misusers and to examine the relation between the prevalences of HIV, hepatitis B virus, and hepatitis C virus infections in homosexual men and intravenous drug misusers and their sexual partners.
DESIGN: Serum samples collected between 1984 and 1988 were tested for hepatitis B virus markers and antibodies against hepatitis C virus by enzyme linked immunosorbent assay (ELISA) and for HIV antibody by enzyme immune analysis and western blotting.
SETTING: Large referral university hospital with an external AIDS clinic in the metropolitan area of Barcelona, Spain.
SUBJECTS: 243 Intravenous drug misusers, 143 of their regular heterosexual partners, and 105 homosexual men. MAIN OUTCOME MEASURES: Prevalences of hepatitis C virus, hepatitis B virus, and HIV infections.
RESULTS: In all, 178 of the 243 (73%) intravenous drug misusers, 16 out of 143 (11%) of their partners, and 17 of the 105 (16%) homosexual men had antibodies against hepatitis C virus. The presence of hepatitis C virus infection was unrelated to sex, age, the presence of HIV or hepatitis B virus infections, or the Centers for Disease Control stage of HIV. In sexual partners of intravenous drug misusers there were strong correlations between the presence of hepatitis C virus infection and that of HIV (p = 0.001) and hepatitis B virus (p = 0.013) infections.
CONCLUSIONS: Intravenous drug misusers have a high risk of acquiring hepatitis C virus, hepatitis B virus, and HIV infections, but the presence of hepatitis C virus infection seems to be unrelated to the presence of the other two viruses. Homosexual men have a high prevalence of HIV and hepatitis B virus infections with a low prevalence of hepatitis C virus infection, the presence of which is not related to that of the other two infections. Conversely, heterosexual partners of intravenous drug misusers have low prevalences of the three virus infections, but the presence of hepatitis C virus infection correlates significantly with the presence of HIV and hepatitis B infections. The rate of sexual transmission of hepatitis C virus seems to be low, even in partners of people known to be seropositive for this virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174705      PMCID: PMC1664292          DOI: 10.1136/bmj.301.6761.1130

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C virus antibody.

Authors:  P P Mortimer; B J Cohen; P A Litton; E M Vandervelde; M F Bassendine; A M Brind; M H Hambling
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Antibodies to hepatitis C virus.

Authors:  M Roggendorf; F Deinhardt; R Rasshofer; J Eberle; U Hopf; B Möller; R Zachoval; G Pape; W Schramm; F Rommel
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

4.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

5.  Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

Authors:  M Colombo; G Kuo; Q L Choo; M F Donato; E Del Ninno; M A Tommasini; N Dioguardi; M Houghton
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

Review 6.  The elusive hepatitis C virus.

Authors:  A J Zuckerman
Journal:  BMJ       Date:  1989-10-07

7.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

8.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

9.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

  10 in total
  31 in total

1.  Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients.

Authors:  G J Kotwal; V K Rustgi; B M Baroudy
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

2.  Sexual transmission of hepatitis C virus.

Authors:  P P Mortimer
Journal:  BMJ       Date:  1990-12-08

3.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

4.  Hepatitis B and C in heterosexual patients with various sexually transmitted diseases.

Authors:  E E Petersen; R Clemens; H L Bock; K Friese; G Hess
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

5.  Sexual behaviour and multiple infections in drug abusers.

Authors:  R C Coppola; G Masia; M L di Martino; G Carboni; E Muggianu; R Piro; P E Manconi
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

6.  HCV status knowledge and risk behaviours amongst intravenous drug users.

Authors:  G Vidal-Trécan; J Coste; I Varescon-Pousson; B Christoforov; A Boissonnas
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 7.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

8.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 9.  Oral sex and the transmission of viral STIs.

Authors:  S Edwards; C Carne
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

10.  Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark.

Authors:  H Westh; A M Worm; B L Jensen; S Kroon; B Kvinesdal; C M Nielsen; P Wantzin
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.